Marilyn Marrari

2.6k total citations
76 papers, 2.0k citations indexed

About

Marilyn Marrari is a scholar working on Immunology, Transplantation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Marilyn Marrari has authored 76 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Immunology, 34 papers in Transplantation and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Marilyn Marrari's work include T-cell and B-cell Immunology (43 papers), Renal Transplantation Outcomes and Treatments (33 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). Marilyn Marrari is often cited by papers focused on T-cell and B-cell Immunology (43 papers), Renal Transplantation Outcomes and Treatments (33 papers) and Monoclonal and Polyclonal Antibodies Research (25 papers). Marilyn Marrari collaborates with scholars based in United States, Netherlands and Brazil. Marilyn Marrari's co-authors include René J. Duquesnoy, Adriana Zeevi, Arend Mulder, Duquesnoy Rj, Kyle Annen, Semíramis Jamil Hadad do Monte, Luiz Cláudio Demes da Mata Sousa, Frans H.J. Claas, R.J. Duquesnoy and Massimo Mangiola and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Immunology.

In The Last Decade

Marilyn Marrari

76 papers receiving 2.0k citations

Peers

Marilyn Marrari
Jean‐Denis Bignon France
C. Gautreau France
Constanze Schönemann Germany
Jonathan Visentin France
Janet Mouradian United States
Philip Dyer United Kingdom
Arcangelo Nocera Italy
Chris Wiebe Canada
Medhat Askar United States
Lloyd D’Orsogna Australia
Jean‐Denis Bignon France
Marilyn Marrari
Citations per year, relative to Marilyn Marrari Marilyn Marrari (= 1×) peers Jean‐Denis Bignon

Countries citing papers authored by Marilyn Marrari

Since Specialization
Citations

This map shows the geographic impact of Marilyn Marrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn Marrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn Marrari more than expected).

Fields of papers citing papers by Marilyn Marrari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn Marrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn Marrari. The network helps show where Marilyn Marrari may publish in the future.

Co-authorship network of co-authors of Marilyn Marrari

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn Marrari. A scholar is included among the top collaborators of Marilyn Marrari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn Marrari. Marilyn Marrari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Qingyong, Mohamed Elrefaei, Jean‐Luc Taupin, et al.. (2023). Chronic lung allograft dysfunction is associated with an increased number of non-HLA antibodies. The Journal of Heart and Lung Transplantation. 43(4). 663–672. 8 indexed citations
2.
Mangiola, Massimo, Marilyn Marrari, Carol Bentlejewski, et al.. (2023). Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II. Frontiers in Immunology. 14. 1110292–1110292. 12 indexed citations
3.
Mangiola, Massimo, Marilyn Marrari, Carol Bentlejewski, et al.. (2022). Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II. The Journal of Heart and Lung Transplantation. 41(7). 952–960. 19 indexed citations
4.
Louis, Kévin, Camila Macedo, É. Bailly, et al.. (2020). Coordinated Circulating T Follicular Helper and Activated B Cell Responses Underlie the Onset of Antibody-Mediated Rejection in Kidney Transplantation. Journal of the American Society of Nephrology. 31(10). 2457–2474. 36 indexed citations
5.
Iasella, Carlo J., Christopher R. Ensor, Marilyn Marrari, et al.. (2020). Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. The Journal of Heart and Lung Transplantation. 39(12). 1417–1425. 23 indexed citations
6.
Duquesnoy, René J. & Marilyn Marrari. (2017). Usefulness of the ElliPro epitope predictor program in defining the repertoire of HLA-ABC eplets. Human Immunology. 78(7-8). 481–488. 24 indexed citations
7.
Yousem, Samuel A., Marilyn Marrari, Matthew R. Morrell, et al.. (2017). Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings. American Journal of Transplantation. 17(5). 1380–1388. 58 indexed citations
8.
Mangiola, Massimo, Marilyn Marrari, Brian Feingold, & Adriana Zeevi. (2017). Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes. Frontiers in Immunology. 8. 4–4. 32 indexed citations
9.
Daniëls, Liesbeth, Marie‐Paule Emonds, Jean‐Louis Bosmans, Marilyn Marrari, & René J. Duquesnoy. (2016). Epitope analysis of DQ6-reactive antibodies in sera from a DQ6-positive transplant candidate sensitized during pregnancy. Transplant Immunology. 38. 15–18. 4 indexed citations
10.
Schroder, Paul M., Caitlin E. Baum, René J. Duquesnoy, et al.. (2014). Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP. Human Immunology. 75(8). 703–708. 21 indexed citations
11.
Duquesnoy, René J., et al.. (2013). Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays. Human Immunology. 74(10). 1271–1279. 56 indexed citations
12.
Duquesnoy, René J. & Marilyn Marrari. (2010). Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants. Transplant Immunology. 24(3). 164–171. 46 indexed citations
13.
Marrari, Marilyn, et al.. (2010). Human Monoclonal Antibody Reactivity With Human Leukocyte Antigen Class I Epitopes Defined by Pairs of Mismatched Eplets and Self-Eplets. Transplantation. 90(12). 1468–1472. 47 indexed citations
14.
Duquesnoy, René J. & Marilyn Marrari. (2009). HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies. Current Opinion in Organ Transplantation. 14(4). 403–409. 52 indexed citations
15.
Marrari, Marilyn & René J. Duquesnoy. (2009). Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Transplant Immunology. 22(3-4). 105–109. 51 indexed citations
16.
Adeyi, Oyedele, Alin Girnita, Marilyn Marrari, et al.. (2005). Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transplant Immunology. 14(1). 53–62. 91 indexed citations
17.
18.
19.
Zeigler, Zella R., Richard K. Shadduck, C Rosenfeld, et al.. (1991). Intravenous gamma globulin decreases platelet‐associated IgG and improves transfusion responses in platelet refractory states. American Journal of Hematology. 38(1). 15–23. 11 indexed citations
20.
Kaslow, Richard A., Mark VanRaden, H. Friedman, et al.. (1990). A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. The Lancet. 335(8695). 927–930. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Denis Bignon Breakdown of academic impact, for papers by C. Gautreau Breakdown of academic impact, for papers by Constanze Schönemann Breakdown of academic impact, for papers by Jonathan Visentin Breakdown of academic impact, for papers by Janet Mouradian Breakdown of academic impact, for papers by Philip Dyer Breakdown of academic impact, for papers by Arcangelo Nocera Breakdown of academic impact, for papers by Chris Wiebe Breakdown of academic impact, for papers by Medhat Askar Breakdown of academic impact, for papers by Lloyd D’Orsogna
Rankless by CCL
2026